Applied Therapeutics Inc (NASDAQ: APLT) kicked off on Tuesday, up 5.56% from the previous trading day, before settling in for the closing price of $0.49. Over the past 52 weeks, APLT has traded in a range of $0.29-$10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 26.57% over the last five years. While this was happening, its average annual earnings per share was recorded 24.67%. With a float of $124.18 million, this company’s outstanding shares have now reached $141.94 million.
Applied Therapeutics Inc (APLT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Applied Therapeutics Inc is 13.77%, while institutional ownership is 61.16%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.48 earnings per share (EPS), lower than consensus estimate (set at -0.16) by -0.32. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.40% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Take a look at Applied Therapeutics Inc’s (APLT) current performance indicators. Last quarter, stock had a quick ratio of 1.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 624.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.44, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Analysing the last 5-days average volume posted by the [Applied Therapeutics Inc, APLT], we can find that recorded value of 0.65 million was lower than the volume posted last year of 2.53 million. As of the previous 9 days, the stock’s Stochastic %D was 49.09%.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 65.63%, which indicates a significant decrease from 87.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0347 in the past 14 days, which was lower than the 0.0402 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4395, while its 200-day Moving Average is $1.0792. Now, the first resistance to watch is $0.5402. This is followed by the second major resistance level at $0.5602. The third major resistance level sits at $0.5885. If the price goes on to break the first support level at $0.4919, it is likely to go to the next support level at $0.4636. Now, if the price goes above the second support level, the third support stands at $0.4436.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
The company with the Market Capitalisation of 74.90 million has total of 144,012K Shares Outstanding. Its annual sales at the moment are 460 K in contrast with the sum of -105,620 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -21,330 K.
